BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Opsumit (Macitentan) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Opsumit (Macitentan)\, from ClinicalTrial
 s.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT05179876-515@assetmemo.bio
DTSTAMP:20261121T004459Z
DTSTART;VALUE=DATE:20270131
DTEND;VALUE=DATE:20270201
SUMMARY:Opsumit (Macitentan): Phase 3 readout est. (NCT05179876)
DESCRIPTION:Opsumit (Macitentan)\, phase 3.\nStudy: A Study Providing Treat
 ment Access in Participants With Pulmonary Hypertension Completing a Paren
 t Study and Having no Other Option\nEstimated primary completion: 31 Janua
 ry 2027. This is a ClinicalTrials.gov estimate\, not a confirmed readout d
 ate\, and it can move.\nDrug page: https://assetmemo.bio/drug/macitentan#u
 pcoming-events\nRegistry record: https://clinicaltrials.gov/study/NCT05179
 876
URL:https://assetmemo.bio/drug/macitentan#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07392281-515@assetmemo.bio
DTSTAMP:20261121T004459Z
DTSTART;VALUE=DATE:20270831
DTEND;VALUE=DATE:20270901
SUMMARY:Opsumit (Macitentan): Phase 1 readout est. (NCT07392281)
DESCRIPTION:Opsumit (Macitentan)\, phase 1.\nStudy: Efficacy and Mechanisms
  of Macitentan for Non-Coronary Obstructive Angina\nEstimated primary comp
 letion: 31 August 2027. This is a ClinicalTrials.gov estimate\, not a conf
 irmed readout date\, and it can move.\nDrug page: https://assetmemo.bio/dr
 ug/macitentan#upcoming-events\nRegistry record: https://clinicaltrials.gov
 /study/NCT07392281
URL:https://assetmemo.bio/drug/macitentan#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
